|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 207/10 | (2006.01) |
| A61K 31/4025 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 2682387 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13172357.9 |
| Date of filing the European patent application | 2009-08-07 | |
| (97) | Date of publication of the European application | 2014-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-07 |
| (46) | Date of publication of the claims translation | 2016-01-11 |
| (30) | Number | Date | Country code |
| 188307 P | 2008-08-08 | US |
| (72) |
Zahler, Robert, B., US
Clark, Roger, B., US
Hunt, Diana, Katharine, US
Plamondon, Louis, CA
Xiao, Xiao-Yi, US
Zhou, Jingye, US
|
| (73) |
Tetraphase Pharmaceuticals, Inc.,
480 Arsenal Street, Suite 110, Watertown, MA 02472,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | C7-fluoru pakeisti tetraciklino junginiai |
| C7-fluoro substituted tetracycline compounds |
| Payment date | Validity (years) | Amount | |
| 2021-01-29 | 12 | 433.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-08-07 |